Analysts Set HealthEquity, Inc. (NASDAQ:HQY) Price Target at $103.83

HealthEquity, Inc. (NASDAQ:HQY) has been given a consensus rating of “Buy” by the twelve brokerages that are currently covering the firm, MarketBeat.com reports. Twelve equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $103.83.

HQY has been the subject of a number of analyst reports. Wells Fargo & Company raised their price objective on shares of HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research note on Thursday, June 20th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Bank of America cut their target price on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. KeyCorp upped their price target on HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a report on Wednesday, June 5th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th.

Insider Activity at HealthEquity

In related news, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the transaction, the director now directly owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Frank Corvino sold 7,705 shares of the stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the sale, the director now directly owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of HealthEquity stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the transaction, the insider now directly owns 89,769 shares in the company, valued at approximately $7,168,952.34. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Motley Fool Asset Management LLC grew its stake in HealthEquity by 3,001.0% during the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after acquiring an additional 3,640,748 shares in the last quarter. Norges Bank purchased a new position in shares of HealthEquity during the fourth quarter valued at about $43,482,000. Vaughan Nelson Investment Management L.P. bought a new stake in shares of HealthEquity in the first quarter worth about $49,443,000. Wasatch Advisors LP lifted its position in shares of HealthEquity by 8.3% in the first quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock worth $604,803,000 after buying an additional 569,249 shares in the last quarter. Finally, Mackenzie Financial Corp boosted its stake in HealthEquity by 16.0% during the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after buying an additional 325,906 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $79.93 on Friday. The company has a 50 day simple moving average of $76.29 and a two-hundred day simple moving average of $79.21. HealthEquity has a fifty-two week low of $61.81 and a fifty-two week high of $88.26. The company has a market capitalization of $6.95 billion, a price-to-earnings ratio of 86.88, a P/E/G ratio of 1.25 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The company had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. Analysts expect that HealthEquity will post 2.25 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.